RARRES2 and metabolic dysfunction-associated steatotic liver disease: Moreover, ratio of tumor to non-tumorous chemerin was higher in patients with NAFLD (power value: 0.98 for comparison of non-tumor and tumor tissues, Table 2) than patients with cryptic disease etiology (p < 0.05; power value: 0.51 for comparison of non-tumor and tumor tissues, Table 2) (Figure 2D).